Clinical Trial Update: Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating the efficacy and safety of etanercept in SAPHO syndrome, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sapho Syndrome

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland | Conditions: SAPHO Syndrome | Phase 2, Phase 3 | Status: RECRUITING